Reimagining MDS & AML: Exploring the Role of TIM-3 in Immune Dysregulation
Graphic Science Series: TIM-3, an Immuno-Myeloid Regulator in MDS and AML
MDS Overview
AML Overview
AML= acute myeloid leukemia; MDS = myelodysplastic syndromes; TIM-3 = T-cell immunoglobulin and mucin domain-3.
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the use(s) under investigation.